Menu
MedChemExpress Webinar: Targeting KRAS Driven Pancreatic Cancer: A Reality after 40 Years

MedChemExpress Webinar: Targeting KRAS Driven Pancreatic Cancer: A Reality after 40 Years

    🔬 About the Webinar

    MedChemExpress is pleased to announce its upcoming scientific webinar:
    “Targeting KRAS Mutations in Pancreatic Cancer: A Reality after 40 Years,”
    presented by Prof. Mariano Barbacid, a pioneering scientist in the field of KRAS oncogene research and one of the leading figures in molecular oncology.

    For over four decades, KRAS has represented one of the most challenging targets in cancer biology. After years of unsuccessful attempts, new generations of inhibitors and therapeutic strategies are finally opening promising avenues toward direct KRAS-targeted therapies.
    In this webinar, Prof. Barbacid will present his team’s latest findings combining preclinical models and translational research, offering valuable insights into how these discoveries are shaping the future of pancreatic cancer treatment.

    📅 Date: Thursday, November 27, 2025
    🕒 Time: 16:00 CET
    🏛 Organizer: MedChemExpress (MCE) Webinar Series
    🎙 Speaker: Prof. Mariano Barbacid, PhD
    Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain

    🧬 Key Topics:

    • Historical overview of KRAS mutation research and the long-standing challenges in drug development.
    • Latest preclinical results from genetically engineered mouse models and their clinical implications.
    • Mechanisms of resistance and emerging strategies to overcome them.
    • Future therapeutic perspectives in KRAS-driven pancreatic cancer.

    👨‍🔬 About the Speaker

    Prof. Mariano Barbacid, PhD is an internationally renowned cancer researcher whose groundbreaking work has transformed our understanding of oncogene biology.
    In 1982, he was among the first to isolate and characterize the HRAS oncogene, marking a milestone in modern cancer research. Currently leading the Experimental Oncology Group at CNIO (Spanish National Cancer Research Center), his laboratory continues to uncover key molecular mechanisms underlying tumor development and progression.

    🎯 Why Attend:

    • Gain first-hand insights from one of the world’s foremost experts in oncology.
    • Learn about the most recent advances in targeting KRAS mutations after decades of research.
    • Receive a certificate of participation upon request.
    • Network with researchers and professionals across oncology, pharmacology, and translational medicine.

    🖋 Registration

    Participation in this webinar is free of charge, but registration is required.
    📌 Register here:
    👉 https://www.medchemexpress.com/webinar-Barbacid-1.html